Edition:
India

Tasly Pharmaceutical Group Co Ltd (600535.SS)

600535.SS on Shanghai Stock Exchange

21.89CNY
10:33am IST
Change (% chg)

¥0.25 (+1.16%)
Prev Close
¥21.64
Open
¥21.75
Day's High
¥21.94
Day's Low
¥21.53
Volume
2,297,335
Avg. Vol
10,247,392
52-wk High
¥34.22
52-wk Low
¥19.71

Latest Key Developments (Source: Significant Developments)

Tasly Pharmaceutical's Unit Sells Stake To Five Firms For $132.5 Million
Tuesday, 10 Jul 2018 

July 10 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>::SAYS UNIT SELLS 75.7 MILLION SHARES, OR 6.99 PERCENT STAKE, TO FIVE FIRMS INCLUDING ALLY BRIDGE LB HEALTHCARE FUND, TRANSGENE SA AND BOCOM INTERNATIONAL <<<3329.HK>>> FOR $132.5 MILLION.  Full Article

Tasly Pharmaceutical Group announces change in accounting policy
Tuesday, 27 Mar 2018 

March 27(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says it changes accounting policy based on accounting standards for business enterprises.  Full Article

Tasly Pharmaceutical's 9-month net profit up 13.5 pct y/y
Wednesday, 25 Oct 2017 

Oct 25 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says 9-month net profit up 13.5 percent y/y.  Full Article

Tasly Pharmaceutical's H1 net profit up 10.4 pct y/y at 756.2 mln yuan
Tuesday, 15 Aug 2017 

Aug 15 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says H1 net profit up 10.4 percent y/y at 756.2 million yuan ($113.25 million).  Full Article

Tasly Pharmaceutical Group says JV receives clinical trial approval
Monday, 17 Jul 2017 

July 15 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:* Says 50 percent owned JV received clinical trial approval from China Food and Drug Administration regarding injection for hepatitis B treatment.  Full Article

Tasly Pharmaceutical Group to pay FY 2016 annual div on June 15
Friday, 9 Jun 2017 

June 9(Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS> ::* Says it will pay FY 2016 dividend to shareholders of record on June 14.* The company's shares will be traded ex-right and ex-dividend on June 15 and the dividend will be paid on June 15.  Full Article

China's Tasly Pharma, France's Pharnext plan JV in China
Tuesday, 9 May 2017 

May 9 (Reuters) - Tasly Pharmaceutical Group Co Ltd <600535.SS>:Says unit plans to invest 20 million euros ($21.79 million) in Pharnext S.A. For 12.6 percent stake.Says it and Pharnext plan to invest 200 million yuan to set up JV in China for technology innovation and product development.  Full Article

Tasly Pharmaceutical's Q1 net profit up 14.8 pct y/y
Friday, 14 Apr 2017 

Tasly Pharmaceutical Group Co Ltd <600535.SS> :Says Q1 net profit up 14.8 percent y/y at 318.1 million yuan ($46.19 million).  Full Article

Tasly Pharmaceutical to pay annual cash div as 5.60 yuan per 10 shares for FY 2016
Sunday, 2 Apr 2017 

Tasly Pharmaceutical Group Co Ltd <600535.SS> :Says it plans to pay annual cash dividend as 5.60 yuan(pre-tax) per 10 shares as FY 2016 div payment.  Full Article

Tasly Pharmaceutical's 2016 profit down, to issue up to 2 bln yuan commercial paper
Thursday, 30 Mar 2017 

Tasly Pharmaceutical Group Co Ltd <600535.SS> : Says 2016 net profit down 20.4 percent y/y .Says it plans to issue up to 2.0 billion yuan ($290.36 million) commercial paper.  Full Article